Shares in Idorsia Pharmaceuticals Ltd are on the rise after the Swiss biotech received US approval for daridorexant, its closely watched sleeping pill which has been shown to help users function normally the next day.
The US Food and Drug Administration has approved 25mg and 50mg doses of daridoxerant, which will be marketed under the...






